Overview

A PK Study of Oraxol in Breast Cancer Patients

Status:
Completed
Trial end date:
2020-12-09
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, single-arm PK study in approximately 24 breast cancer patients for whom paclitaxel treatment is indicated.
Phase:
Phase 1
Details
Lead Sponsor:
Athenex, Inc.
Treatments:
Paclitaxel